Atlas Trials

Relapsed or Refractory Follicular Lymphoma

3 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Relapsed or Refractory Follicular Lymphoma

RecordFirmDate
A Study Evaluating the Efficacy and Safety of Mosunetuzumab in Combination With Lenalidomide in Comparison to Rituximab in Combination With Lenalidomide With a US Extension of Mosunetuzumab in Combination With Lenalidomide in Participants With Follicular Lymphoma (NCT04712097)Hoffmann-La Roche2021-10-27

Track Relapsed or Refractory Follicular Lymphoma automatically

Every clearance here is in the API, with alerts when new ones post.